ANSWER: Eosinophilic esophagitis is an immune-mediated disease of the esophagus. Swallowing difficulty, especially with solid ...

AstraZeneca has recently announced that Fasenra has been approved for severe asthma, specifically for the eosinophilic ...

An endoscopy with dilation and biopsies confirmed that I had eosinophilic esophagitis. My gastroenterologist suggested a one-food elimination diet. I am allergic to the protein in milk, so no dairy ...

The "Eosinophilic Esophagitis - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.Eosinophilic Esophagitis (EoE) is increasingly recognized as a chronic disorder ...

AstraZeneca AZN announced that the FDA has approved its marketed asthma drug, Fasenra (benralizumab), for use in children.

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology to optimize drug ...

AstraZeneca’s initiative is highlighting Fasenra’s potential to manage eosinophilic asthma — a severe form of asthma that may ...

People will hit the pavement this weekend to participate in Kennedy Krieger Institute's "Roar for Kids 5K Run" fundraiser ...

The researchers also observed associations between these allergens and symptomatic URI, but these were not statistically ...

Sanofi beat Q1 earnings estimates with strong revenue and performance of key drugs. Growth lags sector, but has good margins.

Yum Brands Misses Estimates <li /> Promising Outlook as Biotech Sector Advances Cancer Treatments Amidst Rising Diagnoses <li ...

Washington, DC, April 30, 2024 (GLOBE NEWSWIRE) -- Since 1984, the Asthma and Allergy Foundation of America (AAFA) has designated May as National Asthma and Allergy Awareness Month. This year, AAFA is ...